| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $9.98M | $12.25M | $13.58M | $9.91M | $5.73M |
| SG&A | $10.92M | $11.58M | $11.65M | $15.02M | $11.16M |
| Operating Income | -$20.90M | -$23.83M | -$25.24M | -$24.93M | -$16.89M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$19.47M | -$21.82M | -$23.52M | -$24.67M | -$16.53M |
| EPS (basic) | -33.0600 | -1.2700 | -1.9100 | -2.2000 | -1.9000 |
| EPS (diluted) | -33.0600 | -1.2700 | -1.9100 | -2.2000 | – |
| Shares (diluted) | $589.00K | $17.14M | $12.30M | $11.23M | – |